In 2004, InnoTERE was founded by Dr. Berthold Nies and took up its business in Dresden in 2005. As a result of our growth we moved to Pharmapark Radebeul at 1st January 2012. Since 2014 Erich Roethlisberger is our second Managing Director in the areas of marketing and sales.
Long-standing experiences in industrial research and development of biomaterials as well as the location in Dresden with its competences in materials science and biomaterials are solid basements for successful development of innovative products for bone tissue regeneration.
As an innovative company, we have set ourselves the target to explore, develop and produce in close collaboration with researchers and clinicians new products for the treatment of bone damage and finally market as medical devices. One of our development priorities form novel bone cements on the basis of calcium phosphates and polymers. These bone cements enable a minimally invasive treatment of bone defects.
We join together team members and cooperation partners who share our vision of innovative biomaterials for the well-being of affected patients. We further the creativity and skills of our team members and encourage their willingness to cooperate with interdisciplinary partners.
InnoTERE is a founding member of the innovation incentive "Molecular Designed Biological Coating" (MBC) promoted by the Federal Ministry of Education and Research (BMBF) lasting from 2007 to 2010, which was awarded "Selected Landmark 2008 in the Land of Ideas"
In 2008 InnoTERE was successfully certificated EN ISO 9001:2008 and EN ISO 13485:2012 in the scope of design/development, manufacturing and distribution of bone implants, bone cements and bone substitute materials.